Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA

British Journal of Nutrition

Volumn 116, Issue 7, 2016, Pages 1199-1205

  Takagi, Tomohisa ^a   Naito, Yuji ^a   Higashimura, Yasuki ^a   Ushiroda, Chihiro ^a   Mizushima, Katsura ^a   Ohashi, Yuji ^b   Yasukawa, Zenta ^c   Ozeki, Makoto ^c   Tokunaga, Makoto ^c   Okubo, Tsutomu ^c   Katada, Kazuhiro ^a   Kamada, Kazuhiro ^a   Uchiyama, Kazuhiko ^a   Handa, Osamu ^a   Itoh, Yoshito ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^c TAIYO KAGAKU CO LTD   (Japan)

Author keywords

2,4,6 Trinitrobenzene sulfonic acid induced colitis; Microbiota; Partially hydrolysed guar gum; SCFA

Indexed keywords

ACETIC ACID; BUTYRIC ACID; FORMIC ACID; GUAR GUM; ISOBUTYRIC ACID; ISOVALERIC ACID; LACTIC ACID; MYELOPEROXIDASE; PROPIONIC ACID; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR; VALERIC ACID; GALACTAN; MANNAN; MESSENGER RNA; PEROXIDASE; PLANT GUM; TRINITROBENZENESULFONIC ACID; VOLATILE FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES FRAGILIS; BODY WEIGHT LOSS; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; INTESTINE FLORA; LACTOBACILLUS; MALE; MOUSE; MRNA EXPRESSION LEVEL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; COLITIS; COLON; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HYDROLYSIS; INFLAMMATORY BOWEL DISEASES; INTESTINE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY;

ANIMALS; COLITIS; COLON; DISEASE MODELS, ANIMAL; FATTY ACIDS, VOLATILE; GALACTANS; GASTROINTESTINAL MICROBIOME; HYDROLYSIS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; MALE; MANNANS; MICE; MICE, INBRED C57BL; PEROXIDASE; PLANT GUMS; RNA, MESSENGER; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85027955406     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516003068     Document Type: Article

References (36)

1. Asakura K, Nishiwaki Y, Inoue N, et al. (2009) Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol 44, 659-665.
2. Molodecky NA, Soon IS, Rabi DM, et al. (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54.e42; quiz e30.
3. Xavier RJ & Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
4. Hou JK, Abraham B & El-Serag H (2011) Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106, 563-573.
5. Lewis JD & Fisher RL (1994) Nutrition support in inflammatory bowel disease. Med Clin North Am 78, 1443-1456.
6. Yoon SJ, Chu DC & Raj Juneja L (2008) Chemical and physical properties, safety and application of partially hydrolized guar gum as dietary fiber. J Clin Biochem Nutr 42, 1-7.
7. Giannini EG, Mansi C, Dulbecco P, et al. (2006) Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition 22, 334-342.
8. Alam NH, Ashraf H, Sarker SA, et al. (2008) Efficacy of partially hydrolyzed guar gum-added oral rehydration solution in the treatment of severe cholera in adults. Digestion 78, 24-29.
9. Furnari M, Parodi A, Gemignani L, et al. (2010) Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther 32, 1000-1006.
10. Romano C, Comito D, Famiani A, et al. (2013) Partially hydrolyzed guar gum in pediatric functional abdominal pain. World J Gastroenterol 19, 235-240.
11. Yasukawa Z, Naito Y, Takagi T, et al. (2012) Partially hydrolyzed guar gum affects the expression of genes involved in host defense functions and cholesterol absorption in colonic mucosa of db/db male mice. J Clin Biochem Nutr 51, 33-38.
12. Dall'Alba V, Silva FM, Antonio JP, et al. (2013) Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes: a randomised clinical trial. Br J Nutr 110, 1601-1610.
13. Naito Y, Takagi T, Katada K, et al. (2006) Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. J Nutr Biochem 17, 402-409.
14. Ohashi Y, Sumitani K, Tokunaga M, et al. (2015) Consumption of partially hydrolysed guar gum stimulates bifidobacteria and butyrate-producing bacteria in the human large intestine. Benef Microbes 6, 451-455.
15. Harusato A, Naito Y, Takagi T, et al. (2013) BTB and CNC homolog 1 (Bach1) deficiency ameliorates TNBS colitis in mice: role of M2 macrophages and heme oxygenase-1. Inflamm Bowel Dis 19, 740-753.
16. Takagi T, Naito Y, Mizushima K, et al. (2010) Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-alpha expression. Dig Dis Sci 55, 2797-2804.
17. Elson CO, Beagley KW, Sharmanov AT, et al. (1996) Hapteninduced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 157, 2174-2185.
18. Grisham MB, Hernandez LA & Granger DN (1986) Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 251, G567-G574.
19. Higashimura Y, Naito Y, Takagi T, et al. (2013) Oligosaccharides from agar inhibit murine intestinal inflammation through the induction of heme oxygenase-1 expression. J Gastroenterol 48, 897-909.
20. Godon JJ, Zumstein E, Dabert P, et al. (1997) Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 63, 2802-2813.
21. Song Y, Liu C & Finegold SM (2004) Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70, 6459-6465.
22. Rinttila T, Kassinen A, Malinen E, et al. (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97, 1166-1177.
23. Matsuki T, Watanabe K, Fujimoto J, et al. (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70, 7220-7228.
24. Ushida K & Sakata T (1998) Effect of pH on oligosaccharide fermentation by porcine cecal digesta. Anim Sci Tech 69, 100-107.
25. Rutgeerts P, Vermeire S & Van Assche G (2009) Biological therapies for inflammatory bowel diseases. Gastroenterology 136, 1182-1197.
26. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126, 1620-1633.
27. Sokol H, Seksik P, Furet JP, et al. (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15, 1183-1189.
28. Andoh A, Kuzuoka H, Tsujikawa T, et al. (2012) Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol 47, 1298-1307.
29. Koleva PT, Valcheva RS, Sun X, et al. (2012) Inulin and fructooligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats. Br J Nutr 108, 1633-1643.
30. De Preter V, Machiels K, Joossens M, et al. (2015) Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 64, 447-458.
31. Macfarlane GT & Macfarlane S. (2011) Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 45, S120-S127.
32. Atarashi K, Tanoue T, Shima T, et al. (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341.
33. Round JL & Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107, 12204-12209.
34. Smith PM, Howitt MR, Panikov N, et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573.
35. Atarashi K, Umesaki Y & Honda K (2011) Microbiotal influence on T cell subset development. Semin Immunol 23, 146-153.
36. Zhang YJ, Li S, Gan RY, et al. (2015) Impacts of gut bacteria on human health and diseases. Int J Mol Sci 16, 7493-7519.